v3.25.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current Assets:    
Cash $ 527,978 $ 1,530,924
Prepaid expenses and other current assets 298,192 184,873
Vendor deposits 169,363
Total Current Assets 995,533 1,715,797
In-process research and development 18,647,903
Vendor deposits 178,476
Deferred offering costs 44,727 57,238
Total Assets 1,040,260 20,599,414
Current Liabilities:    
Accounts payable 9,805,129 9,337,267
Accrued expenses and other current liabilities 2,960,698 1,894,041
Total Current Liabilities 12,765,827 11,231,308
Deferred tax liability 851,659
Total Liabilities 12,765,827 12,082,967
Commitments and contingencies (Note 7)
Stockholders’ (Deficit) Equity:    
Common stock 809 251
Additional paid-in-capital 125,187,156 121,155,922
Accumulated deficit (136,906,365) (112,632,559)
Treasury stock, at cost, 7 shares at September 30, 2025 and December 31, 2024 (7,168) (7,168)
Total Stockholders’ (Deficit) Equity (11,725,567) 8,516,447
Total Liabilities and Stockholders’ (Deficit) Equity 1,040,260 20,599,414
Series A Preferred Stock [Member]    
Stockholders’ (Deficit) Equity:    
Preferred stock
Series B Preferred Stock [Member]    
Stockholders’ (Deficit) Equity:    
Preferred stock $ 1 $ 1